Literature DB >> 19167174

Progestogens and brain: an update.

N Pluchino1, A Cubeddu, A Giannini, S Merlini, V Cela, S Angioni, A R Genazzani.   

Abstract

Each synthetic progestins has its own specific activities on different tissues, which can vary significantly between progestins of different classes and even within the same class. Indeed, different progestins may support or oppose the effects of estrogen depending on the tissue, thereby supporting the concept that the clinical selection of progestins for HRT is critical in determining potential positive or detrimental effects. These actions might be particularly relevant in the central nervous system (CNS) where progesterone (P) has pivotal roles besides reproduction and sexual behavior, going from neuropsychological effects to neuroprotective functions. Growing evidence supports the idea that synthetic progestins differ significantly in their brain effects, and clinical studies indicate that these differences also occur in women. Molecular and cellular characterization of the signaling properties of synthetic progestins in brain cells is therefore required and is hoped will lead to a better clinical utilization of the available compounds, as well as to new concepts in the engineering of new molecules. The aim of the present paper is to briefly review and compare neuroendocrine effects of progestogens with special reference to P metabolism into neuroactive steroids and the opioids system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19167174     DOI: 10.1016/j.maturitas.2008.11.023

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  18 in total

1.  Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint I. Role of progesterone receptors.

Authors:  James Hassell; Chandra Suma Johnson Miryala; Cindy Hiegel; Lynda Uphouse
Journal:  Horm Behav       Date:  2011-05-20       Impact factor: 3.587

Review 2.  Hormonal Contraceptives and Mood: Review of the Literature and Implications for Future Research.

Authors:  Thalia Robakis; Katherine E Williams; Lexi Nutkiewicz; Natalie L Rasgon
Journal:  Curr Psychiatry Rep       Date:  2019-06-06       Impact factor: 5.285

Review 3.  Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model.

Authors:  Jennifer L Gordon; Susan S Girdler; Samantha E Meltzer-Brody; Catherine S Stika; Rebecca C Thurston; Crystal T Clark; Beth A Prairie; Eydie Moses-Kolko; Hadine Joffe; Katherine L Wisner
Journal:  Am J Psychiatry       Date:  2015-01-13       Impact factor: 18.112

Review 4.  Progesterone and autoimmune disease.

Authors:  Grant C Hughes
Journal:  Autoimmun Rev       Date:  2011-12-13       Impact factor: 9.754

5.  Relationship satisfaction and outcome in women who meet their partner while using oral contraception.

Authors:  S Craig Roberts; Katerina Klapilová; Anthony C Little; Robert P Burriss; Benedict C Jones; Lisa M DeBruine; Marion Petrie; Jan Havlícek
Journal:  Proc Biol Sci       Date:  2011-10-12       Impact factor: 5.349

6.  Repeated estradiol benzoate treatment protects against the lordosis-inhibitory effects of restraint and prevents effects of the antiprogestin, RU486.

Authors:  Lynda Uphouse; Cindy Hiegel; Giovanny Martinez; Christian Solano; William Gusick
Journal:  Pharmacol Biochem Behav       Date:  2015-07-17       Impact factor: 3.533

7.  Evidence for a role of progesterone in menstrual cycle-related variability in prepulse inhibition in healthy young women.

Authors:  Veena Kumari; Joanna Konstantinou; Andrew Papadopoulos; Ingrid Aasen; Lucia Poon; Rozmin Halari; Anthony J Cleare
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

8.  Allopregnanolone's attenuation of the lordosis-inhibiting effects of restraint is blocked by the antiprogestin, CDB-4124.

Authors:  Lynda Uphouse; Cindy Hiegel
Journal:  Pharmacol Biochem Behav       Date:  2014-03-18       Impact factor: 3.533

9.  RU486 blocks effects of allopregnanolone on the response to restraint stress.

Authors:  Lynda Uphouse; Sarah Adams; Chandra Suma Johnson Miryala; James Hassell; Cindy Hiegel
Journal:  Pharmacol Biochem Behav       Date:  2012-10-06       Impact factor: 3.533

10.  Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology.

Authors:  Antonio Molina-Carballo; Fuensanta Justicia-Martínez; Francisco Moreno-Madrid; Isabel Cubero-Millán; Irene Machado-Casas; Laura Moreno-García; Josefa León; Juan-de-Dios Luna-Del-Castillo; José Uberos; Antonio Muñoz-Hoyos
Journal:  Psychopharmacology (Berl)       Date:  2014-03-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.